6.5 C
New York
Saturday, March 2, 2024

Heron Therapeutics Gets Back On Track (NASDAQ:HRTX)

Heron Therapeutics Gets Back On Track (NASDAQ:HRTX)


photos/iStock via Getty Images

In July, I wrote about Therapeutic Heron (NASDAQ:HRTX), emphasizing that the restructuring could usher in a new era for the company. I rated HRTX a buy based on the potential of its recently launched Aponvie, the



Source link

Latest stories